California Law Banning Copay Coupons Didn’t Boost Generic Drug Use, Study Finds

A 2017 California law that banned drugmaker copay coupons failed to increase the use of generic drugs, according to a study from Brigham and Women’s Hospital in Boston. The study, published June 15 in JAMA, found that the law did not meet its goal to boost use of generic drugs instead of patients’ relying on copay coupons ...

Read More

Medicaid Enrollment Hits Record 80 Million

The pandemic-caused recession and a federal requirement that states keep Medicaid beneficiaries enrolled until the national emergency ends swelled the pool of people in the program by more than 9 million over the past year, according to a report released Thursday. The latest figures show Medicaid enrollment grew from 71.3 million in February 2020, when ...

Read More

Delta Coronavirus Strain Is Growing Fast In California, With Risk For Unvaccinated People

The highly infectious delta coronavirus variant is rising fast in California, with cases more than doubling in the past month and tripling in one Bay Area county, according to genomic sequencing results reported by state and local public health departments. The first California cases of delta, a variant that emerged in India, were reported in ...

Read More

New COVID-19 Workplace Rules Align with CDC, State Health Dept. Guidelines

This week, the Standards Board of the California Division of Occupational Safety and Health (Cal/OSHA) adopted revisions to the COVID-19 emergency workplace rules. The changes approved at the Standards Board’s June 17 meeting make Cal/OSHA’s COVID-19 Emergency Temporary Standard (ETS) more consistent with face mask guidelines from the Centers for Disease Control and Prevention (CDC) and California ...

Read More

CDC Director: Delta Variant To ‘Probably’ Become Dominant Strain In U.S.

Research from Scotland released this week showed the variant made hospitalization more than twice as likely than for patients with the Alpha variant.

Read More

Pricey Drugs Paid By Medicare Lack Cost-Effectiveness Data

Nearly $50 billion or a third of Medicare Part D costs in 2016 were for drugs with absent cost-effectiveness analyses, according to a report from JAMA Network Open. Why it matters: The lack of a quality analysis that weighs the relative cost with outcomes of these drugs may create hurdles toward efforts aimed at addressing drug spending ...

Read More

Don’t Deny Vacation Due to Recent Use of COVID Sick Leave

My employee used most of her COVID-19 Supplemental Paid Sick Leave over the last couple of weeks. Now she wants to take a week’s vacation. Can I deny the vacation request since several other employees in that department, who have been working lots of extra hours to cover her missed shifts, also want to take ...

Read More

Breaking News: Supreme Court Upholds Obamacare In 7-2 Ruling

The Supreme Court on Thursday upheld ObamaCare against the latest Republican challenge, preserving the landmark law and its key protections for millions of people with preexisting health conditions.

Read More

Obamacare Wins For The 3rd Time At The Supreme Court

The U.S. Supreme Court upheld the Affordable Care Act for the third time on Thursday, leaving in place the broad provisions of the law enacted by Congress in 201o. The vote was 7 to 2.

Read More

Supreme Court Leaves Affordable Care Act Intact

The Supreme Court on Thursday rejected a challenge to the Affordable Care Act, the third time it has preserved the 2010 healthcare law.

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square